[Vascular access and anemia in hemodialysis].
Fernández-Gallego
J
J
López
V
V
Toledo
R
R
Martín Reyes
G
G
D000368:Aged; D000740:Anemia / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002408:Catheters, Indwelling / Q000009:adverse effects*; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000627:therapeutic use; D005260:Female; D006397:Hematinics / Q000627:therapeutic use; D006403:Hematologic Tests; D006801:Humans; D008297:Male; D011446:Prospective Studies; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods*; D012307:Risk Factors
D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa